restraining order barring Lilly from using its sales force that markets Amylin's Byetta from also marketing Tradjenta. Eli Lilly recently agreed to market the latter with German Boehringer Ingelheim. Amylin has more to lose here. The biotech says it's...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Amylin Scores First in Court
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account